Intravenous Immunoglobulin Market|Detailed Survey On Key Trends, Size, Share, Growth, Leading Players & Business Opportunities 2027

(The Express Wire via Comtex)

Fortune Business Insights predicts the Global Intravenous Immunoglobulin Market to reach a value of US$ 15,789.1 Mnfrom US$ 9,787.6 Mn. The forecast period is set from 2018 and the market is expected to grow at a CAGR of 6.2%. All information related to the market is provided in the report, titled, “Intravenous Immunoglobulin Market Size, Share and Global Trend by Indication (Primary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Guillain-Barré Syndrome (GBS), Immune Thrombocytopenic Purpura (ITP), Multifocal Motor Neuropathy (MMN)), Form (Liquid, Lyophilized), End User (Hospitals, Clinics, Homecare) and Geography Forecast till 2025”. The rising incidenceof immunodeficiency diseases in both emerging and developed nations is propelling growth of the Intravenous Immunoglobulin market.

Browse Complete Report [email protected]

As per the report, the Global Intravenous Immunoglobulin Market is expected to be dominated by the primary immunodeficiency segment with respect to segmentation by indication. In 2017, the primary immunodeficiency segment held 28.6% of the overall intravenous immunohlobulins market share. This is owing to the increasing prevalence of primary immunodeficiency that there is rise in demand for immunoglobulins. Beside this, the assending focus on treating primary immunodeficiency is further expected to boost the market. Owing to the factors mentioned above, this segment is anticipated to continue dominating the market in the forecast duration as well.

Increasing Adoption of Immunoglobulins to Help Asia Pacific Register Fastest Growth

According to the report, The Global Intravenous Immunoglobulin Market wasdominatedby North America with a market value of US$ 5,587.4 Mn in 2017. The region is likley to remain dominant through the forecast period as well due to the presence of first line treatment for critical immune disorders. Other factors boosting the market in the region are rising number of patients and efficient results of the intravenous immunoglobulin treatment.

On the other side, the market in Asia Pacific is anticipated to grpow at faster rate in the coming years on account of the rise in awareness about the treatment option avaiulable for immunologic deficiencies. In addition to this, the rise in adoption and expenditure of immunoglobulins in economies such as Japan, China,andIndiais anticipated to boost the market in the region.

Increasing Cases of Hypogammaglobulinemia and Other Chronic Diseases to Boost Global Market

The increasing geriatric population and their susceptibility towards various health issues areboosting the global intravenoiusimmunogulobulin market. The increasing number of hemophilic patients around the world is adding to the growth of the market. This, coupoled with the prevailing number of diseases such as hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy (CIDP), and others is also fueling the demand for immunoglobuolin treatment, ultimately boosting the market.

On the flipside, the market may face challenges in terms of strict government rules and regulations with regard to the use of intravenous immunoglobulin products. In addition to this, the high risks associated with the use of these products may result in side effects and this, may further repress the growth of the market affecting its revenue globally.

Get [email protected]

Key Segmentation:

By Indication

  • Primary Immunodeficiency
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • Guillain-Barré Syndrome (GBS)
  • Immune Thrombocytopenic Purpura (ITP)
  • Multifocal Motor Neuropathy (MMN)
  • Others

By Form

  • Liquid
  • Lyophilized

By End User

  • Hospitals
  • Clinics
  • Homecare

By Geography

  • North America (the U.S., and Canada)
  • Europe (Germany, U.K., France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia Pacific (China, India, Japan, Australia, South East Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America
  • Middle East and Africa (GCC, South Africa, and Rest of Middle East and Africa)

Request a Sample Copy of the Global Intravenous Immunoglobulin Market Research Report:

Some major points from Table of Content:

  1. Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

  1. Executive Summary
  2. MarketDynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

  1. Key Insights

4.1. Pipeline Analysis

4.2. Overview of Regulatory Scenario by Key Regions

4.3. Key Industry Developments

4.4. Number (Estimated) of Primary Immunodeficiency (PI) Patients by Key Countries

4.5. Overview of Reimbursement Scenario

  1. Global Intravenous Immunoglobulin Market Analysis, Insights and Forecast, 2015-2025

5.1. Key Findings /Summary

5.2. Market Analysis, Insights and Forecast By Indication

5.2.1. Primary Immunodeficiency

5.2.2. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

5.2.3. Guillain-Barré Syndrome (GBS)

5.2.4. Immune Thrombocytopenic Purpura (ITP)

5.2.5. Multifocal Motor Neuropathy (MMN)

5.2.6. Others

5.3. Market Analysis, Insights and Forecast By Form

5.3.1. Liquid

5.3.2. Lyophilized

5.4. Market Analysis, Insights and Forecast By End User

5.4.1. Hospitals

5.4.2. Clinics

5.4.3. Homecare

5.5. Market Analysis, Insights and Forecast By Region

5.5.1. North America

5.5.2. Europe

5.5.3. Asia Pacific

5.5.4. Latin America

5.5.5. Middle East and Africa

  1. North America Intravenous Immunoglobulin Market Analysis,Insights and Forecast, 2015-2026

6.1. Key Findings / Summary

6.2. Market Analysis By Indication

6.2.1. Primary Immunodeficiency

6.2.2. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

6.2.3. Guillain-Barré Syndrome (GBS)

6.2.4. Immune Thrombocytopenic Purpura (ITP)

6.2.5. Multifocal Motor Neuropathy (MMN)

6.2.6. Others

6.3. Market Analysis By Form

6.3.1. Liquid

6.3.2. Lyophilized

6.4. Market Analysis By End User

6.4.1. Hospitals

6.4.2. Clinics

6.4.3. Homecare

6.5. Market Analysis By Country

6.5.1. U.S.

6.5.2. Canada

  1. Europe Intravenous Immunoglobulin Market Analysis, Insights and Forecast, 2015-2026

7.1. Key Findings / Summary

7.2. Market Analysis By Indication

7.2.1. Primary Immunodeficiency

7.2.2. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

7.2.3. Guillain-Barré Syndrome (GBS)

7.2.4. Immune Thrombocytopenic Purpura (ITP)

7.2.5. Multifocal Motor Neuropathy (MMN)

7.2.6. Others

7.3. Market Analysis By Form

7.3.1. Liquid

7.3.2. Lyophilized

7.4. Market Analysis By End User

7.4.1. Hospitals

7.4.2. Clinics

7.4.3. Homecare

7.5. Market Analysis By Country/ Sub-Region

7.5.1. U.K.

7.5.2. Germany

7.5.3. France

7.5.4. Spain

7.5.5. Italy

7.5.6. Scandinavia

7.5.7. Rest of Europe

  1. Asia Pacific Intravenous Immunoglobulin Market Analysis, Insights and Forecast, 2015-2026

8.1. Key Findings / Summary

8.2. Market Analysis By Indication

8.2.1. Primary Immunodeficiency

8.2.2. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

8.2.3. Guillain-Barré Syndrome (GBS)

8.2.4. Immune Thrombocytopenic Purpura (ITP)

8.2.5. Multifocal Motor Neuropathy (MMN)

8.2.6. Others

8.3. Market Analysis By Form

8.3.1. Liquid

8.3.2. Lyophilized

8.4. Market Analysis By End User

8.4.1. Hospitals

8.4.2. Clinics

8.4.3. Homecare

8.5. Market Analysis By Country/ Sub-Region

8.5.1. Japan

8.5.2. China

8.5.3. India

8.5.4. Australia

8.5.5. Southeast Asia

8.5.6. Rest of Asia Pacific

  1. Latin America Intravenous Immunoglobulin Market Analysis,Insights and Forecast, 2015-2026

9.1. Key Findings / Summary

9.2. Market Analysis By Indication

9.2.1. Primary Immunodeficiency

9.2.2. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

9.2.3. Guillain-Barré Syndrome (GBS)

9.2.4. Immune Thrombocytopenic Purpura (ITP)

9.2.5. Multifocal Motor Neuropathy (MMN)

9.2.6. Others

9.3. Market Analysis By Form

9.3.1. Liquid

9.3.2. Lyophilized

9.4. Market Analysis By End User

9.4.1. Hospitals

9.4.2. Clinics

9.4.3. Homecare

9.5. Market Analysis By Country/ Sub-Region

9.5.1. Brazil

9.5.2. Mexico

9.5.3. Rest of Latin America

  1. Middle East andAfrica Intravenous Immunoglobulin Market Analysis, Insights and Forecast,2015-2026

10.1. Key Findings / Summary

10.2. Market Analysis By Indication

10.2.1.Primary Immunodeficiency

10.2.2.Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

10.2.3.Guillain-Barré Syndrome (GBS)

10.2.4.Immune Thrombocytopenic Purpura (ITP)

10.2.5.Multifocal Motor Neuropathy (MMN)


10.3. Market Analysis By Form



10.4. Market Analysis By End User




10.5. Market Analysis By Country/ Sub-Region

10.5.1.GCC Countries

10.5.2.South Africa

10.5.3.Rest of Middle East and Africa

  1. Competitive Analysis

11.1. Key Industry Developments

11.2. Global Market Share Analysis (2018)

11.3. Competition Dashboard

11.4. Comparative Analysis Major Players

11.5. Company Profiles (Overview, Productsand Services, SWOT Analysis, RecentDevelopments, Strategies, Financials (Based on Availability))

11.5.1.Shire (Takeda Pharmaceutical Company Limited)

11.5.2.CSL Behring

11.5.3.Grifols, S.A.

11.5.4.Kedrion S.p.A


11.5.6.Bio Products Laboratory Ltd.

11.5.7.Biotest AG

11.5.8.China Biologic Products Holdings, Inc.

11.5.9.LFB SA

11.5.10.Shanghai RAASBlood Products Co., Ltd.

  1. Strategic Recommendations


Order Full [email protected]

Top Key Players Covered:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the global Intravenous Immunoglobulin market. Some of the companies operating the global Intravenous Immunoglobulin market are;

  • CSL Behring
  • Grifols, S.A.
  • Kedrion S.p.A
  • Octapharma
  • Bio Products Laboratory Ltd.
  • Biotest AG
  • China Biologic Products Holdings, Inc.
  • LFB SA and Shanghai RAAS Blood Products Co., Ltd.

Grifols, S.A., Leading Market with Better Product Offerings

Analysts at Fortune Business Insights foresees the Grifols, S.A., to emerge as the dominant player in the global market for intravenous immunoglobulin market. This is because this company was leading the market in the year 2017 as well, all because oftheir product offerings and the usual route of administration, whioch ultimately dominated a considerate proportion of share ion the market. Besides this, Grifols, S.A., accounts for largest revenues from well developed regions namely Europe and North America.

Other companies operating in the global iontravenous immunoglobulin market are Bio Products Laboratory Ltd., Kedrion S.p.A, Grifols, S.A., Biotest AG, China Biologic Products Holdings, Inc., Octapharma, and CSL Behring.

Secondary Data Sources That We Refer To

  • Annual reports, investor presentation, SEC filings, and press releases of companies operating in the market
  • Studies published by relevant associations MedTech Europe; American College of Radiology; Cancer Council Australia; Japan Hospital Association, etc.), government sources (Centers for Disease Control and Prevention, Ministry of Health, Labour and Welfare, Japan; National Health Service, England, etc.), international organizations (World Health Organization, The Organization for Economic Co-operation and Development, Eurostat, etc.), and articles published by Research Gate, NCBI, etc.
  • Website, reports, and press releases of end user facilities Hospitals, Ambulatory Surgery Centres, Clinics
  • Industry journals and paid databases

Secondary Research Is Conducted To Derive The Following Information

  • Details such as revenues, market share, strategies, growth rate, product and their pricing by region/country for all major companies
  • Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.
  • Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility
  • Number of procedures and average price of procedures
  • Replacement rate and pricing of capital equipment
  • Market dynamics in relation to the market under focus Drivers, restraints, trends, and opportunities
  • Market and technological trends, new product developments, product pipeline.


Vesical Catheters Market 2021 | Worldwide Opportunities, Driving Forces, Future Potential 2026

Adhesive Bandages Market Overview, Shares, Growing Demand, Market Size, Growth, Production, Types, Applications and Forecast Report 2027

Reconstruction Mesh Market | Latest Industry Trends, Size, Share, Statistics, Applications and Competition Strategies by 2028

Telemedicine Technologies and Services Market Growth (Status and Outlook) 2021-2027|Size, Share Growth, Trends

Medical Lifting Slings Market Size, Share, Industry Analysis and Regional Forecast 2020-2027

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Intravenous Immunoglobulin Market|Detailed Survey On Key Trends, Size, Share, Growth, Leading Players & Business Opportunities 2027

comtex tracking